will be a reverse merger. Maybe with a medical device company that has an application for oral mucositis? Maybe the officers of the merging company will be far more qualified to advance our drug and their device through clinical trials towards approval and, therefore, will assume control of the merged entities? Would such a scenario possibly inform why Ehrlich pulled $1MM out of the company when it's in such a fragile fiscal state? Under such a scenario, Ehrlich would have nothing better to do than sit poolside on his pile of shares in Boca and continue to enrich himself on the backs of others.
Sounds like a good gig to me. What would you call a vehicle that would allow you to do nothing but line your pockets in Boca?
Anyone still believe we're not on the precipice of clearing the decks of existing shareholders with a reverse split?